# Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis

> **NCT00004808** · PHASE2 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 78 (—)

## Conditions studied

- Histoplasmosis
- Sporotrichosis
- Blastomycosis

## Interventions

- **DRUG:** fluconazole

## Key facts

- **NCT ID:** NCT00004808
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 78 (—)
- **Last updated:** 2006-06-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004808, "Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*